Related Experiment Video
Updated: Aug 8, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Methylation of the BRCA1 gene in sporadic breast cancer
1Department of Haematology-Oncology, University of Adelaide, Australia. adobrovic@medicine.adelaide.edu.au
Abstract:
Mutations of the BRCA1 gene in tumor DNA from patients with sporadic breast cancer have not yet been observed. Nevertheless, BRCA1 activity is markedly decreased in invasive breast tumors. Previous reports have shown that hypermethylation of the promoter region is an alternative mechanism to mutation for the inactivation of tumor suppressor genes. We examined the BRCA1 promoter region for hypermethylation by Southern blotting. Hypermethylation was observed in two of seven sporadic breast carcinomas but not in any normal tissues. The hypermethylation was not an artifact because a control region was unmethylated in the two tumors. Although not all tumors were hypermethylated, these observations are consistent with an important role for epigenetic mechanisms in human cancer.
Insights
BRCA1 gene activity decreases in breast tumors. Promoter hypermethylation, an epigenetic change, was found in some sporadic breast cancers, suggesting its role in cancer development.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Mutations in the BRCA1 gene are not observed in sporadic breast cancer.
- BRCA1 gene activity is significantly reduced in invasive breast tumors.
- Hypermethylation of gene promoter regions can inactivate tumor suppressor genes.
Purpose of the Study:
- To investigate the role of BRCA1 promoter hypermethylation in sporadic breast cancer.
- To determine if epigenetic mechanisms contribute to breast cancer development.
Main Methods:
- Southern blotting was used to examine the BRCA1 promoter region for hypermethylation.
- Tumor DNA from sporadic breast cancer patients and normal tissues were analyzed.
Main Results:
- Hypermethylation of the BRCA1 promoter was detected in 2 out of 7 sporadic breast carcinomas.
- No hypermethylation was observed in normal tissues.
- A control region remained unmethylated in the affected tumors, confirming the specificity of BRCA1 hypermethylation.
Conclusions:
- Epigenetic alterations, specifically BRCA1 promoter hypermethylation, play a role in sporadic breast cancer.
- These findings highlight the importance of epigenetic mechanisms in human cancer development.
- Further research is warranted to explore the full impact of BRCA1 hypermethylation in breast cancer.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
09:24Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Related Concept Videos
Epigenetic Regulation
Inheritance of Chromatin Structures
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Epigenetic Regulation
X-chromosome...